Home Newsfeeds Atlantic Equities Downgrades Twilio to Neutral

Atlantic Equities Downgrades Twilio to Neutral

Atlantic Equities analyst Peter Sazel downgrades Twilio (NYSE:TWLO) from Overweight to Neutral.

byBenzinga Newsdesk

August 5, 2022

1 minute read

Atlantic Equities analyst Peter Sazel downgrades Twilio (NYSE:TWLO) from Overweight to Neutral.

Deutsche Bank Maintains Hold on Clorox, Lowers Price Target to $147

By Benzinga Newsdesk

March 20, 1:00 PM

Deutsche Bank analyst Steve Powers maintains Clorox (NYSE:CLX) with a Hold and lowers the price target from $152 to $147.

CLX

Analyst Ratings

What 5 Analyst Ratings Have To Say About Huntsman

By Benzinga Insights

May 8, 10:01 AM

Huntsman (NYSE:HUN) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish…

HUN

News

Sigma Lithium Ships 22,000 Tons Of Lithium Concentrate; Glencore Prepaid 50% At Premium Prices Of 7.5% Of Quoted LME/Fastmarkets Lithium Hydroxide Price

By Benzinga Newsdesk

February 5, 3:41 PM

Sigma Lithium announces that it is completing the loading of 22,000 tonnes of Quintuple Zero Green Lithium to Glencore at the Port of Vitoria tonight.Glencore has prepaid 50% for the shipment of Sigma's Quintuple

SGML

Endocrine Diseases-Focused Crinetics Pharmaceuticals Highlights Favorable Initial Findings From Mid-Stage Study

By Vandana Singh

December 19, 1:51 PM

Crinetics Pharmaceuticals Inc (NASDAQ: CRNX) released initial findings from its ongoing open-label Phase 2 carcinoid syndrome (CS) study of paltusotine, an oral, once-daily investigational compound being developed for

CRNX

Atlantic Equities Downgrades Twilio to Neutral

Related Posts

Deutsche Bank Maintains Hold on Clorox, Lowers Price Target to $147

What 5 Analyst Ratings Have To Say About Huntsman

Sigma Lithium Ships 22,000 Tons Of Lithium Concentrate; Glencore Prepaid 50% At Premium Prices Of 7.5% Of Quoted LME/Fastmarkets Lithium Hydroxide Price

Endocrine Diseases-Focused Crinetics Pharmaceuticals Highlights Favorable Initial Findings From Mid-Stage Study